Family Smoking Prevention and Tobacco Control Act Regulatory Research

NIH-FDA Tobacco Control Regulatory Research
CFDA 93.678 Active Grant Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$66.1M FY2026
$59.1M
FY24
$57.9M
FY25
$66.1M
FY26*
* estimated

Program Objective

The Family Smoking Prevention and Tobacco Control Act provides the authority to regulate tobacco product manufacturing, distribution, and marketing. An interagency partnership between the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) Center for Tobacco Products fosters tobacco regulatory research. Regulatory research will provide scientific evidence to inform the implementation of this authority.

Eligibility

Eligible Applicants

  • Nonprofit Organization
  • State
  • Federally Recognized Tribal Government
  • Tribal Government (other)
  • Other Special District Government
  • Department/Agency of U.S. Territorial Gov
  • U.S. Federal Government
  • U.S. State Government
  • U.S. Territory Government
  • Department/Agency of U.S. State
  • Municipality/Township Government
  • County Government
  • For-Profit Organization
  • Tribally Designated Housing Authority
  • School District
  • Public Housing Authority
  • Local Government Consortium
  • Other

Applicants should review the eligibility information in individual notices of funding opportunities.

Beneficiaries

  • Health Professional
  • Education Professional
  • Scientist / Researcher
  • Trainee
  • Specific Restrictions (Determined at NOFO Level)
  • Nonprofit Organization
  • Veteran (including dependents)
  • Other

Other public institutions/organizations

How to Apply

Award Procedure

All applications for research grants, cooperative agreements, training, and SBIR and STTR grants are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by the Advisory Council of the NIH Institute or Center that will manage the award. All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance.

Decision Timeline

  • Approval: > 180 Days
  • Renewal interval: > 180 Days
Program details & compliance

Description

With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, NIH provides scientific evidence and data to inform FDA’s regulatory actions.

Through this partnership, NIH and FDA establish a comprehensive research agenda in tobacco regulatory science. NIH provides the infrastructure for the solicitation, review, and management of scientific research, and several NIH Institutes and Centers have long supported tobacco-related research as part of their missions. The FDA provides the expertise, authority, and resources to support research responsive to FDA’s regulatory authority.

Mission Categories

Primary: General Health and Medical

Other categories:
Prevention and Control (includes Suicide Prevention)Research and Development

Use of Funds

Allowed Uses

(1) Research project grants provide support for clearly defined projects or a small group of related research activities, and when appropriate, support of research conferences; (2) program project and center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) exploratory/development and clinical exploratory/developmental grants encourage the development of new research activities in categorical program areas; (4) cooperative agreements support single or a group of related research activities with significant involvement of federal staff; and (5) research training grants including fellowships and institutional training grants, career development grants and loan repayment contracts.

Restrictions

All activities must be within the scope of the FDA Center for Tobacco Products' authorities. Please note specific restrictions listed in individual notices of funding opportunity.

Reporting & Compliance

Audit Required
Yes — Ad-hoc
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart F — Audit Requirements

Contacts

Kay Wanke — Director, Tobacco Regulatory Science Program
3014511856
National Institutes of Health 6705 Rockledge Drive Room 733, MSC 7990, Bethesda, MD 20892
Rachel Mandal — Director, Tobacco Regulatory Science Program
3014803477
National Institutes of Health 6705 Rockledge Drive Room 733, MSC 7990, Bethesda, MD 20892
Data from SAM.gov Federal Assistance Listings. Source published: 2026-05-27. Spec v2.0. Last synced: 2026-05-28 07:22:53.